Introduction
Current tumor models
Technique | Advantages | Disadvantages |
---|---|---|
Traditional cell culture (monolayer and spheroids) | - Easily maintained and expanded | - Cancer cells lose grow potential in vitro |
- Genetic manipulation | - Often only one clone expands | |
- High-throughput drug screening | - Lower biological stability | |
- Most favorable cost-benefit | - Inability to represent the clinical cancer spectrum | |
Xenografts | - In vivo culture | - Difficult genetic manipulation |
- High heterogeneity possible | - Graft failure | |
- Complete microenvironment | - Time and resource consuming | |
- Lack of high-throughput drug screening | ||
Organoids | - Long term expansion | - Unknown capability to capturing whole spectrum of in vivo heterogeneity |
- Mimicking in vivo conditions | - Time consuming initiating a model | |
- High-throughput drug screening | - No microenvironment | |
- Tissue subtype modeling |
Organoids
Definition
Origin of organoids
Tissue/Organ | Derived from adult stem cells | Derived from pluripotent stem cells |
---|---|---|
Adenohypophysis | + | |
Bile duct | + | |
Brain | + | |
Colon | + | |
Esophagus | + | |
Fallopian tube | + | |
Gallbladder | + | |
Inner ear | + | |
Kidney | + | |
Liver | + | + |
Lung | + | + |
Mammary gland | + | + |
Pancreas | + | + |
Prostate | + | |
Retina/Optic cup | + | |
Salivary gland | + | |
Small intestine | + | + |
Stomach | + | + |
Taste buds | + | |
Thyroid | + | |
Ovary | + | + |
Tumor-derived organoids
Relevant applications
Gene editing
Modeling disease and development
Drug testing and screening
Cancer type | Aim of study |
---|---|
Breast | - Elucidate pathways of tumorigenesis and metastasis |
- Detect drug response of organoids | |
- Validation of disease-causing genomic variations | |
- Organoid biobank | |
Colorectal | - Genetic diversity of patient- derived tumor organoids and the original tumor biopsy |
- Organoid biobank | |
- Personalized medicine | |
- Modeling specific subtype of colon cancer | |
Endometrium | - Organoid biobank |
- Precision medicine | |
Glioblastoma | - Organoid model of non-epithelial tumor |
Liver | - Organoid biobank |
- Detection of driver mutations | |
Pancreatic | - Pancreatic ductal adenocarcinoma modeling and drug screening |
- Organoid model | |
Prostate | - Tumor modeling |
- Lineage and cell transition monitoring | |
Renal | Method for renal carcinoma 3D culture |
Stomach and esophageal | - Genomic-based classification of gastric cancer |
- New driver mutation detection | |
- Personalized medicine | |
- Organoid biobank | |
- Long-term 3D cultures of human gastric stem cells and bacterial infection study |